SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-085077
Filing Date
2020-03-25
Accepted
2020-03-25 16:16:58
Documents
6
Effectiveness Date
2020-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 d865611ds8.htm S-8 54127
2 EX-5.1 d865611dex51.htm EX-5.1 7356
3 EX-23.1 d865611dex231.htm EX-23.1 1646
4 EX-23.2 d865611dex232.htm EX-23.2 1672
5 GRAPHIC g865611page6a.jpg GRAPHIC 2973
6 GRAPHIC g865611page6b.jpg GRAPHIC 6911
  Complete submission text file 0001193125-20-085077.txt   79819
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237380 | Film No.: 20742356
SIC: 2834 Pharmaceutical Preparations